These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload. Fung EB, Harmatz P, Milet M, Ballas SK, De Castro L, Hagar W, Owen W, Olivieri N, Smith-Whitley K, Darbari D, Wang W, Vichinsky E, Multi-Center Study of Iron Overload Research Group. Am J Hematol; 2007 Apr; 82(4):255-65. PubMed ID: 17094096 [Abstract] [Full Text] [Related]
3. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pakbaz Z, Fischer R, Fung E, Nielsen P, Harmatz P, Vichinsky E. Pediatr Blood Cancer; 2007 Sep; 49(3):329-32. PubMed ID: 17554789 [Abstract] [Full Text] [Related]
11. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease. Inati A, Musallam KM, Wood JC, Sheikh-Taha M, Daou L, Taher AT. Eur J Haematol; 2009 Dec 01; 83(6):565-71. PubMed ID: 19737308 [Abstract] [Full Text] [Related]
12. Chronically transfused pediatric sickle cell patients are protected from cardiac iron overload. Kaushik N, Eckrich MJ, Parra D, Yang E. Pediatr Hematol Oncol; 2012 Apr 01; 29(3):254-60. PubMed ID: 22303979 [Abstract] [Full Text] [Related]
14. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy. Brown K, Subramony C, May W, Megason G, Liu H, Bishop P, Walker T, Nowicki MJ. J Pediatr Hematol Oncol; 2009 May 01; 31(5):309-12. PubMed ID: 19415007 [Abstract] [Full Text] [Related]
15. Pancreatic iron loading in chronically transfused sickle cell disease is lower than in thalassaemia major. Noetzli LJ, Coates TD, Wood JC. Br J Haematol; 2011 Jan 01; 152(2):229-33. PubMed ID: 21118197 [Abstract] [Full Text] [Related]
19. Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions. Fung EB, Harmatz PR, Milet M, Balasa V, Ballas SK, Casella JF, Hilliard L, Kutlar A, McClain KL, Olivieri NF, Porter JB, Vichinsky EP, Multi-Center Iron Overload Research Group. Transfusion; 2008 Sep 01; 48(9):1971-80. PubMed ID: 18513257 [Abstract] [Full Text] [Related]
20. Nontransferrin-bound iron in transfused patients with sickle cell disease. Inati A, Musallam KM, Cappellini MD, Duca L, Taher AT. Int J Lab Hematol; 2011 Apr 01; 33(2):133-7. PubMed ID: 21382180 [Abstract] [Full Text] [Related] Page: [Next] [New Search]